Search results
Axiom Real-Time Metrics Announces Leadership Transition
Morningstar· 6 days agoAxiom Real-Time Metrics Announces Leadership Transition Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency of Phase I, II and III clinical trials and observational
Hacking India’s Electronic Voting Machine is Next to Impossible – AIM
Analytics India Magazine· 2 hours agoElon Musk, the CEO of Tesla and SpaceX, whipped up a political storm of sorts in India ever since he wrote that post on X criticising electronic voting machines (EVMs). Musk set the ball rolling ...
For Stenting in Calcified Lesions, Which Guide Is Best?
Medscape· 1 day agoIn the first randomized trial to compare imaging guidance for percutaneous interventions, optical...
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 6 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a...
Oracle's (ORCL) Expanding Partner Base to Boost Cloud Revenues
Zacks via Yahoo Finance· 6 days agoOracle (ORCL) expands its partner base with Microsoft and Google, which is expected to boost the...
The pros and cons of pooling supplies for clinical trials
Clinical Trials Arena via Yahoo Finance· 6 days agoInventory management systems such as Sharp’s Clinventory solution automate the management of drug...
Viridian Therapeutics to begin Phase III trials of thyroid eye disease treatment
Clinical Trials Arena via Yahoo Finance· 6 days agoUS-based biotechnology company Viridian Therapeutics has announced plans to begin two Phase III...
'I'm a Longevity Expert, and This Is the One Vitamin I'm Begging Everyone Over 50 to Get More Of'
Parade via Yahoo News· 3 days agoBMC Geriatrics. Vitamin D Deficiency Increases Mortality Risk in the UK Biobank: A Nonlinear...
Hybrid working from home improves retention without damaging performance - Nature
Nature· 6 days agoIn July 2021, Trip.com decided to evaluate hybrid WFH after seeing its popularity amongst US tech firms. The first step took place on 27 July 2021, when the firm surveyed 1,612 eligible engineers ...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 6 days agoRevive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and ...